- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Recurrent/Metastatic Breast Cancer in Norway
Total 302 results
-
Spexis AGTerminatedMetastatic Breast Cancer | Locally Recurrent Breast CancerSpain, Belgium, United States, United Kingdom, Korea, Republic of, Taiwan, Italy, Russian Federation, Czechia, France, Brazil, Argentina, Ukraine
-
Geron CorporationCompletedLocally Recurrent or Metastatic Breast CancerUnited States, Canada
-
AstraZenecaCompletedMetastatic Breast CancerNorway
-
Vestre Viken Hospital TrustRecruiting
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingUnresectable Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Metastatic Breast Adenocarcinoma | Metastatic HER2-Positive Breast Carcinoma | Recurrent Breast Adenocarcinoma | Recurrent HER2-Positive Breast Carcinoma | Unresectable HER2-Positive Breast CarcinomaUnited States, Canada
-
Oslo University HospitalBristol-Myers Squibb; Helse Stavanger HF; Sorlandet Hospital HF; Cliniques universitaires... and other collaboratorsCompletedBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive TumorNorway, Belgium
-
Haukeland University HospitalActive, not recruitingLocally Advanced Breast Cancer | Metastatic Breast CarcinomaNorway
-
Oslo University HospitalThe Research Council of NorwayCompleted
-
Oslo University HospitalRecruitingLocally Advanced Pelvic Cancer That Require Pelvic ExenterationNorway
-
Region Örebro CountyHelsinki University Central Hospital; Hospital Clinic of Barcelona; University... and other collaboratorsRecruitingQuality of Life | Advanced Breast Cancer | Metastatic Breast Cancer | Toxicity | Older PatientsSweden, Finland, Greece, Italy, Norway, Spain
-
University Hospital, AkershusNorwegian Cancer Society; Helse Sor-Ost; ChromaDex, Inc.; Norwegian Breast Cancer...RecruitingHeart Failure | Breast Cancer | Metastatic Breast Cancer | Cardiotoxicity | Cancer Therapy-Related Cardiac DysfunctionNorway
-
OncoTherapy Science, Inc.RecruitingRelapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast CancerUnited States
-
University Hospital, AkershusVestre Viken Hospital Trust; NovartisRecruitingBreast Cancer | Locally Advanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Luminal A Breast Cancer | Luminal B Breast CancerNorway
-
Cancer Trials IrelandCompletedMetastatic Breast CancerSpain, Ireland, Israel, Finland, Portugal, France, Germany, Norway
-
University of BergenHaukeland University HospitalActive, not recruitingStage III Breast Cancer AJCC V7Norway
-
Oslo University HospitalCompletedBreast Cancer SurgeryNorway
-
Steinar AamdalTerminatedRecurrent Epithelial Ovarian CancerNorway
-
Oslo University HospitalActive, not recruiting
-
Norwegian School of Sport SciencesUppsala University; Haukeland University Hospital; University of Agder; Norwegian... and other collaboratorsCompleted
-
Cancer Registry of NorwayRecruitingHealth, Subjective | Breast Cancer PatientsNorway
-
Oslo University HospitalKarolinska Institutet; Hoffmann-La Roche; Rigshospitalet, Denmark; Helse Stavanger... and other collaboratorsCompletedTriple Negative Breast Cancer | Cancer, BreastNorway, Denmark
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | HER2/Neu Negative | Breast Adenocarcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States, South Africa
-
Catharina Ziekenhuis EindhovenRecruitingRecurrent Rectal CancerNetherlands, Sweden, Belgium, Norway, Portugal
-
Norwegian School of Sport SciencesUniversity of Oslo; Memorial Sloan Kettering Cancer Center; Oslo University HospitalCompleted
-
IpsenTerminated
-
Oslo University HospitalTerminated
-
Nordlandssykehuset HFCompleted
-
Vestre Viken Hospital TrustOslo University HospitalActive, not recruiting
-
Oslo University HospitalActive, not recruitingBreast CancerNorway
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Esophageal Carcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | Stage IV Esophageal Cancer AJCC v7 | Metastatic Esophageal Squamous Cell Carcinoma | Metastatic Esophageal Adenocarcinoma | Recurrent Gastroesophageal Junction Adenocarcinoma | Recurrent Esophageal Adenocarcinoma and other conditionsUnited States
-
GlaxoSmithKlineCompletedMetastatic Breast Cancer | Neoplasms, BreastUnited States
-
University Hospital of North NorwayCompleted
-
Helse Stavanger HFUnknownMetastatic Pancreatic CancerNorway
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaboratorsRecruitingRecurrent Prostate Cancer | Metastatic Prostate CancerFinland, Norway, Estonia, Denmark
-
Torbjorn OmlandOslo University Hospital; Novartis; University Hospital of North Norway; Helse... and other collaboratorsActive, not recruitingHeart Failure | Breast Cancer FemaleNorway
-
Genentech, Inc.UnknownMetastatic Breast CancerAustralia, Spain, Greece, Mexico, Russian Federation, United States, Singapore, Canada, Peru, Taiwan, Korea, Republic of, Philippines, Netherlands, United Kingdom, France, Brazil, Ukraine, Sweden, Guatemala, Panama, Norway, Uruguay
-
Memorial Sloan Kettering Cancer CenterRecruitingNon Small Cell Lung Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Metastatic Non-Small Cell Lung CarcinomaUnited States
-
Hoffmann-La RocheNorwegian Radium HospitalCompleted
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingMetastatic Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerAustria, Belgium, Italy, Spain, France, Switzerland, Denmark, Norway, Sweden
-
PfizerCompletedAdvanced Breast Cancer | Metastatic Breast CancerUnited States, Canada
-
Oslo University HospitalUllevaal University Hospital; University of Tromso; Helse Stavanger HF; Sorlandet... and other collaboratorsCompletedBreast CancerNorway
-
University Hospital of North NorwayNorwegian Cancer SocietyTerminated
-
University Hospital, AkershusUniversity of Oslo; AstraZeneca; Norwegian Cancer SocietyCompletedHeart Failure | Breast CancerNorway
-
Dompé Farmaceutici S.p.APRA Health SciencesCompletedMetastatic Breast CancerUnited States, Spain, Belgium, Italy, France, Czechia, Poland
-
Oslo University HospitalThe Research Council of Norway; St. Olavs HospitalActive, not recruitingStage I Breast Cancer | Stage II Breast Cancer | DCIS Grade 3 | LCIS, Lobular Carcinoma in SituNorway
-
Cancer Registry of NorwayExtrastiftelsenCompleted
-
Oslo University HospitalSouth-Eastern Norway Regional Health AuthorityCompleted
-
Novartis PharmaceuticalsTerminatedMetastatic Breast CancerUnited States, Germany, Belgium, Canada, France, Italy, Spain, United Kingdom, Austria, Argentina, Sweden, Hungary, Korea, Republic of, Lebanon, Bulgaria, Greece, Thailand, Netherlands, Colombia, Norway, Finland, Poland
-
Novartis PharmaceuticalsCompletedAdvanced, Metastatic Breast CancerUnited States, Canada, France, Italy, Spain, Taiwan, Hungary, Turkey, Belgium, Germany, Netherlands, Singapore, Austria, Czechia, Australia, Israel, Russian Federation, Sweden, United Kingdom, Korea, Republic of, Thailand, Lebanon, ... and more